Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

New Study Supports Transposon Theory Of Aging

XTALKS VITALS NEWS

As the DNA structure in key areas begins to loosen, transposons are allowed to insert themselves into other genes, potentially disrupting their function and affecting health.

Tweetables from this article:

Tweet: Researchers are hesitant to declare causation between #transposon activity and aging-related #health problems http://ctt.ec/h0033+Researchers are hesitant to declare causation between transposon activity and aging-related health problems.

Share this!

September 20, 2016 | by Sarah Hand, M.Sc.

A recent study has contributed further evidence that transposonsDNA elements capable of moving around the genome – could play a role in deteriorating health associated with advanced age. The research – published in the journal, Proceedings of the National Academy of Sciences – could aid development of life-extending treatments capable of counteracting the effects of transposons on health.

Previous studies have shown that the mechanisms which normally keep these transposons from migrating to other areas of the genome, namely the firmly wound structure of heterochromatin, deteriorate as we age. As the DNA structure in key areas begins to loosen, transposons are allowed to insert themselves into other genes, potentially disrupting their function and affecting health.

“In this report the big step forward is towards the possibility of a true causal relationship,” said Dr. Stephen Helfand, Brown University professor of biology and senior author of the study. “So far there have been associations and suggestions that to all of us make sense, but the difference in science is that you need the data to back up your opinion.”

Using green fluorescent protein (GFP) as a marker, the researchers were able to study the movement of transposons in the genome of Drosophila fruit flies. As the flies aged, Helfand and his colleagues noted an increase in transposon activity.



Interesting, the transposon activity did not increase linearly as the flies aged; transposon movement throughout the genome was at its peak as the flies began to die. “Flies reach a certain age and then it takes off more exponentially,” commented Dr. Jason Wood, faculty investigator on the project.

In another experiment, the research team found that feeding the flies a low-calorie diet was able to significantly delay the point at which transposon activity began to increase. Dietary changes have already been shown to be successful interventions at prolonging lifespan.

Helfand and his team also manipulated genes known to regulate DNA structure and organization into heterochromatin, which are conserved in both Drosophila and humans. The researchers found that upregulation of the gene Su(var)3-9 – a gene which induces DNA to form a heterochromatic structure – extended the flies’ lifespan by 20 days.

Despite the evidence provided by the multiple experiments performed in this study, the researchers are hesitant to declare causation between transposon activity and aging-related health problems. “They make a strong story,” said Helfand. “We're starting to put the flesh on the skeleton.”

Instead, co-author Wood speculates that transposons are likely just one piece of a complex aging puzzle. “There are lots of potential mechanisms that influence the aging process,” said Wood. “There are a lot of things going on, but we think this is one of them.”


Keywords: Transposon, DNA, Aging


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
Researchers Identify Role of ApoE4 Gene as Possible Drug Target in Alzheimer’s Disease

September 21, 2017 - A team of neurology researchers at Washington University School of Medicine in St. Louis have found that in the presence of the ApoE4 protein, another protein known as tau forms tangles in the brain which contributes to neuronal damage characteristic of Alzheimer’s disease.

Featured In: Life Science News


New Guidelines Address CAR-T Immunotherapy Toxicities to Prevent Patient Deaths

September 20, 2017 - Clinicians at The University of Texas MD Anderson Cancer Center have published new guidelines in the journal, Nature Reviews Clinical Oncology, which could help in the management of these toxicities.

Featured In: Biotech News, Drug Safety News


Microneedle Skin Patch Could Treat Common Metabolic Disorders

September 19, 2017 - Researchers at Columbia University Medical Center (CUMC) and the University of North Carolina have developed a microneedle skin patch impregnated with a drug capable of converting white fat into calorie-burning brown fat.

Featured In: Medical Device News


LEAVE A COMMENT
 
  
THE XTALKS VITALS INDUSTRY BLOG

Five Reasons Why Toronto is Emerging as a Major Life Sciences Hub

REGISTER FOR THESE WEBINARS

Development and Manufacture of Highly Potent API Drug Products Throughout the Clinical Phases


Innovation through Integration – Providing Next Generation Biomedical Devices and Interconnects


Clinical Payments Case Studies: Improving Efficiency, Cash Management, and Compliance


Why Phase 3 Trials Fail: Oncology Case Studies and Lessons Learned


Copyright © 2016-2017 Honeycomb Worldwide Inc.